Participant Login

Investing in Cancer Research

Australia

Gynaecological cancers will affect

6,073 families

in Australia this year.

Can Too has invested in

3 researchers

working on gynaecological cancers.

Cancer Research Gynaeological Cancers

Gynaecological cancer patients have

69% survival

thanks to cancer research.

What Are Gynaecological Cancers?

Gynaecological cancers are named according to the organ or part of the body where they first develop, including ovary, uterus, cervix, vagina and vulva.

Ovarian cancer affects the ovaries, a pair of solid, oval-shaped organs producing hormones and eggs (ova).

Uterine cancer begins in the main body of the uterus, a hollow organ about the size and shape of an upside-down pear. The uterus is where the baby grows when a woman is pregnant.

Cervical cancer begins in the cervix, the lower, cylinder-shaped part of the uterus. Its upper margin is connected to the uterus, while its lower margin is connected to the vagina.

Vaginal cancer begins in the vagina (also called the birth canal), a muscular tube-like channel that extends from the cervix to the external part of the females sex organs (vulva).

Vulval cancer begins in the vulva, the outer part of the female reproductive system. It includes the opening of the vagina, the inner and outer lips (also called labia minora and labia majora), the clitoris and the mons pubis (soft, fatty
mound of tissue, above the labia).

Other types of gynaecological cancers include fallopian tube cancer and placenta cancer (a pregnancy-related cancer).

(Source: Cancer Australia - Gynaecological Cancers Fact sheet)

Our Investment in Gynaecological Cancer Research

Sign up to our newsletter